ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$15.32 USD
-0.52 (-3.28%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $15.31 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Earnings News For ACAD
-
Acadia (ACAD) Up 10% Since Last Earnings Report: Can It Continue?
-
Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues
-
Acadia Pharmaceuticals (ACAD) Beats Q2 Earnings and Revenue Estimates
-
Acadia: Q2 Earnings Snapshot
-
Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Acadia (ACAD) Up 0.6% Since Last Earnings Report: Can It Continue?
-
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
-
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
-
Acadia: Q1 Earnings Snapshot
-
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
-
Why Is Acadia (ACAD) Down 23.4% Since Last Earnings Report?
-
Acadia (ACAD) Q4 Earnings Lag, Sales Beat Estimates, Stock Down
-
Acadia: Q4 Earnings Snapshot
-
Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates
-
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
-
Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up
-
Acadia: Q3 Earnings Snapshot
-
Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
-
Acadia (ACAD) Down 0.7% Since Last Earnings Report: Can It Rebound?
-
Acadia (ACAD) Q2 Earnings & Revenues Beat Estimates, '23 View Up
-
Acadia Pharmaceuticals (ACAD) Q2 Earnings and Revenues Beat Estimates